Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Ischemic heart disease (IHD) is one of the leading causes of mortality worldwide. Preserving functionality and preventing arrhythmias of the heart are key principles in the management of patients with IHD. Levosimendan, a unique calcium (Ca(2+)) enhancer with inotropic activity, has been introduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaballah, Mahmoud, Penttinen, Kirsi, Kreutzer, Joose, Mäki, Antti-Juhana, Kallio, Pasi, Aalto-Setälä, Katriina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947267/
https://www.ncbi.nlm.nih.gov/pubmed/35326497
http://dx.doi.org/10.3390/cells11061045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947267/
https://www.ncbi.nlm.nih.gov/pubmed/35326497
http://dx.doi.org/10.3390/cells11061045

Ejemplares similares